Stock comparison
Side-by-side financials for BRTX and DVA. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DVA is larger
Market cap data is available for the leading company in this comparison.
Market value leader
DVA
Latest market capitalization comparison.
Revenue leader
DVA
BRTX: $359.70K vs DVA: $13.64B.
Profit leader
DVA
BRTX: -$14.24M vs DVA: $1.08B.
Margin leader
DVA
BRTX: -3959.4% vs DVA: 7.9% net margin.
| Metric | BRTX | DVA |
|---|---|---|
| Market cap | - | $14.73 B |
| US-listed rank | - | #749 |
| Revenue (latest FY) | $359.70K | $13.64B |
| Net income (latest FY) | -$14.24M | $1.08B |
| Net margin | -3959.4% | 7.9% |
| P/E (trailing FY) | - | 13.7x |
| SEC filings | 735 | 3,248 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, BioRestorative Therapies, Inc. reported $359.70K in revenue while DAVITA INC. reported $13.64B.
Full pages: BioRestorative Therapies, Inc. and DAVITA INC., or browse the full rankings.